About 1 result found for searched term "Remtolumab" (0.131 seconds)
Cat.No. | Name | Target |
---|---|---|
M24797 | Remtolumab | TNF Receptor |
ABT-122 | ||
Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.